Milestone Pharmaceuticals Inc. announced the grant of 113,000 stock options to three new employees on January 2, 2025, as part of its 2021 Inducement Plan. The options, priced at $2.17 per share, will ...
Shares of Milestone Pharmaceuticals traded 150% higher after the company reported regulatory guidance and updated its clinical development plan for etripamil nasal spray designed for self-administered ...
Milestone Pharmaceuticals announced a Commercial Launch Plan investor event, indicating proactive engagement with investors and transparency about its upcoming strategies. The event will detail the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results